Afficher la couverture 'A major response to carboplatin in a metastatic triple-negative breast cancer patient with somatic mutation of BRCA1 and RAD51B: When chemotherapy meets precision medicine | Seguin, L.' en grand format
/5

0 avis

A major response to carboplatin in a metastatic triple-negative breast cancer patient with somatic mutation of BRCA1 and RAD51B: When chemotherapy meets precision medicine

Archive ouverte

Seguin, L. | Chaffanet, M. | Sabatier, R. | Jose, A. | Garnier, S. | Carbuccia, N. | Guille, A. | Birnbaum, D. | Bertucci, F. | Goncalves, A.

Edité par CCSD ; Elsevier -

Conference on Molecular Analysis for Personalised Therapy (MAP), Paris, FRANCE, SEP 14-15, 2018. International audience

Consulter en ligne

Suggestions

Du même auteur

RETROSPHER. ERBB2 amplification detection in the plasma at diagnosis for early high-risk HER2-positive breast cancer

Archive ouverte | Sabatier, R. | CCSD

Conference on Molecular Analysis for Personalised Therapy (MAP), Paris, FRANCE, SEP 14-15, 2018. International audience

Circulating tumour DNA as an early marker of recurrence and treatment efficacy in ovarian carcinoma, the CIDOC study

Archive ouverte | Sabatier, R. | CCSD

Conference on Molecular Analysis for Personalised Therapy (MAP), Paris, FRANCE, SEP 14-15, 2018. International audience

A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study

Archive ouverte | Collignon, A. | CCSD

International audience. Targeted next-generation sequencing (tNGS) and ex vivo drug sensitivity/resistance profiling (DSRP) have laid foundations defining the functional genomic landscape of acute myeloid leukemia (...

Chargement des enrichissements...